Omega Fund IV GP, L.P.
SEC CIK 1528383 · EDGAR
BoughtSold
Most active insiders at NUVB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hattersley Gary | CSO | — | $3.88M |
| 2 | Liu Dongfang | Chief MEDICAL Off | — | $1.87M |
| 3 | Wentworth Kerry | Chief REGULATORY Off | — | $1.47M |
| 4 | Hanley David C. | CHIEF TECHNICAL Ops | — | $1.43M |
| 5 | Markel Stacy | CHRO | — | $753.2K |
| 6 | Sauvage Philippe | CFO | — | $286.4K |
| 7 | Mashal Robert | Dir | $118.3K | — |
| 8 | Makunje Moses | SEE REMARKS | — | — |
Omega Fund IV GP, L.P. made no open-market trades at NUVB in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-17 | 2021-12-15 | NUVB | Nuvation Bio Inc. | Omega Fund IV GP, L.P. | 10% | S - Sale | $10.07 | -500.0K | 22.96M | -2% | -$5.04M | |
| M | 2021-11-23 | 2021-11-19+ | REPL | Replimune Group, Inc. | Omega Fund IV GP, L.P. | 10% | S - Sale | $34.58 | -45.4K | 4.76M | -0.9% | -$1.57M |
| M | 2021-11-18 | 2021-11-16+ | REPL | Replimune Group, Inc. | Omega Fund IV GP, L.P. | 10% | S - Sale | $33.50 | -2,594 | 4.81M | -0.1% | -$86.9K |
| M | 2021-11-16 | 2021-11-12+ | REPL | Replimune Group, Inc. | Omega Fund IV GP, L.P. | 10% | S - Sale | $33.66 | -24.0K | 4.81M | -0.5% | -$808.4K |
| M | 2021-11-12 | 2021-11-10+ | REPL | Replimune Group, Inc. | Omega Fund IV GP, L.P. | 10% | S - Sale | $33.61 | -18.3K | 4.84M | -0.4% | -$614.7K |
| M | 2021-11-10 | 2021-11-08+ | REPL | Replimune Group, Inc. | Omega Fund IV GP, L.P. | 10% | S - Sale | $33.66 | -11.4K | 4.86M | -0.2% | -$382.2K |
Purchase Sale Sale after option exercise All abbreviations